- Home
- WNC vs OCS Comparison
WNC vs OCS Comparison
Compare WNC & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNC
- OCS
- Stock Information
- Founded
- WNC 1985
- OCS 2003
- Country
- WNC United States
- OCS Switzerland
- Employees
- WNC N/A
- OCS N/A
- Industry
- WNC Construction/Ag Equipment/Trucks
- OCS Biotechnology: Pharmaceutical Preparations
- Sector
- WNC Industrials
- OCS Health Care
- Exchange
- WNC Nasdaq
- OCS Nasdaq
- Market Cap
- WNC 850.9M
- OCS 717.3M
- IPO Year
- WNC 1991
- OCS N/A
- Fundamental
- Price
- WNC $17.25
- OCS $16.98
- Analyst Decision
- WNC Hold
- OCS Strong Buy
- Analyst Count
- WNC 1
- OCS 5
- Target Price
- WNC $18.00
- OCS $29.20
- AVG Volume (30 Days)
- WNC 574.9K
- OCS 38.1K
- Earning Date
- WNC 01-30-2025
- OCS 11-07-2024
- Dividend Yield
- WNC 1.88%
- OCS N/A
- EPS Growth
- WNC N/A
- OCS N/A
- EPS
- WNC N/A
- OCS N/A
- Revenue
- WNC $2,126,025,999.00
- OCS $1,027,571.00
- Revenue This Year
- WNC N/A
- OCS $6.87
- Revenue Next Year
- WNC N/A
- OCS $884.16
- P/E Ratio
- WNC N/A
- OCS N/A
- Revenue Growth
- WNC N/A
- OCS N/A
- 52 Week Low
- WNC $15.94
- OCS $10.11
- 52 Week High
- WNC $30.07
- OCS $18.00
- Technical
- Relative Strength Index (RSI)
- WNC 35.45
- OCS 61.09
- Support Level
- WNC $19.05
- OCS $15.45
- Resistance Level
- WNC $20.63
- OCS $17.50
- Average True Range (ATR)
- WNC 0.76
- OCS 0.47
- MACD
- WNC -0.32
- OCS 0.09
- Stochastic Oscillator
- WNC 9.29
- OCS 65.57
About WNC Wabash National Corporation
Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The company's mission is to enable customers to succeed with breakthrough ideas and solutions that help them move everything from the first to the final mile. It designs and manufactures a diverse variety of products, including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.